Trauma: Clinical Trials

8 trials for Trauma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 8
Phase 25Completed 5

Follow Trauma: new trials by email Literature Review of Trauma trials Research Report on Trauma

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
Fibrinogen concentrate, Placebo Comparator - Trauma, Injury
Phase 1 / Phase 2CompletedSunnybrook Health Sciences Centre502014-10-012016-04-14
Cell Therapy for Craniofacial Bone Defects
Ixmyelocel-T, Autogenous Bone Grafting - Cleft Palate, Trauma
Phase 1 / Phase 2CompletedUniversity of Michigan182012-08-012017-05-04
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
Human Fibrinogen Concentrate, Placebo - Trauma, Massive Hemorrhage
Phase 1 / Phase 2CompletedMedical University Innsbruck672011-09-012015-12-08
Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-01 Study
Omega-3 Polyunsaturated Fatty Acid - Trauma, Posttraumatic Stress Disorder
Phase 1 / Phase 2CompletedJapan Science and Technology Agency152008-05-012012-07-03
Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels
rhu-pGelsolin, Placebo - Low Gelsolin, Trauma
Phase 1 / Phase 2CompletedCritical Biologics Corporation402008-03-012010-09-29
Correlation Research Study: IQ2, NcIQ and IQ101
Noninvasive Hemodynamic Patient Monitor - Heart Failure, Dyspnea
Phase 1CompletedNoninvasive Medical Technologies, Inc.252007-06-012007-06-26
GW406381 In Patients With Peripheral Nerve Injury
GW406381 - Hyperalgesia, Neurodynia
Phase 1CompletedGlaxoSmithKline402003-09-012009-02-23
Adjuvant Nutrition for Critically Ill Trauma Patients
Juven (nutritional), HMB (nutritional) - Trauma
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1002003-03-012010-01-14

Narrower conditions

Wounds and Injuries (8)  ·  Afibrinogenemia (1)  ·  Burns (1)  ·  Cleft Palate (1)  ·  Dyspnea (1)  ·  Heart Failure (1)  ·  Hemorrhage (1)  ·  Hemostatic Disorders (1)  ·  Hyperalgesia (1)  ·  Hypertension (1)  ·  Infections (1)  ·  Meretoja syndrome (1)  ·  Neuralgia (1)  ·  Pain (1)  ·  Peripheral Nerve Injuries (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Cardiovascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Pathologic Processes (2)  ·  Respiratory Tract Diseases (2)  ·  Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Coagulation Protein Disorders (1)  ·  Congenital Abnormalities (1)  ·  Craniofacial Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Heart Diseases (1)

Interventions

Fibrinogen (2)  ·  Docosahexaenoic Acids (1)  ·  GW406381X (1)  ·  Saline Solution (1)

Sponsors

Critical Biologics Corporation (1)  ·  GlaxoSmithKline (1)  ·  Japan Science and Technology Agency (1)  ·  Medical University Innsbruck (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Noninvasive Medical Technologies, Inc. (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  University of Michigan (1)

Countries

United States (2)  ·  Austria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Japan (1)  ·  United Kingdom (1)

Top investigators

Barto Nascimento, MD MSc (1)  ·  Darnell Kaigler, DDS, PhD (1)  ·  David Seaberg, MD (1)  ·  Dietmar Fries, Prof. MD (1)  ·  John A Rathmacher, Ph.D. (1)  ·  Joseph A Tyndall, MD (1)  ·  Kevin Ferguson, MD (1)  ·  Richard C Straube, MD (1)  ·  Selene Tam, PhD (1)  ·  Wai M Chan, MBBS (1)  ·  Yutaka Mastuoka, M.D., Ph.D. (1)

Results publications

PMID 20520307, PMID 21303552, PMID 21720194, PMID 33109923

NIH funding

R43DK061818 (1)